ACHILLES Trademark

Trademark Overview

On Tuesday, April 2, 2024, a trademark application was filed for ACHILLES with the United States Patent and Trademark Office. The USPTO has given the ACHILLES trademark a serial number of 98480576. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, October 15, 2024. This trademark is owned by Achilles Therapeutics UK Limited. The ACHILLES trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacture of therapeutic drugs, namely custom manufacture of cell therapies, cancer therapies, neoantigen-specific T cells, TCR-engineered T cells, cancer vaccines and neoantigen vaccines

Medical and veterinary preparations for therapeutic purposes; preparations for cancer therapy; antibodies; vaccines; personalised cancer vaccines; neoantigen vaccines; preparations for cell therapy; neoantigen-specific T cells; TCR-engineered T cells; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes

Medical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines

Scientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies, including neoantigen-specific T cells and TCR-engineered T cells; scientific research in human and animal cell therapy; scientific research into vaccines, including personalised cancer vaccines and neoantigen vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
achilles

General Information

Serial Number98480576
Word MarkACHILLES
Filing DateTuesday, April 2, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, October 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCustom manufacture of therapeutic drugs, namely custom manufacture of cell therapies, cancer therapies, neoantigen-specific T cells, TCR-engineered T cells, cancer vaccines and neoantigen vaccines
Goods and ServicesMedical and veterinary preparations for therapeutic purposes; preparations for cancer therapy; antibodies; vaccines; personalised cancer vaccines; neoantigen vaccines; preparations for cell therapy; neoantigen-specific T cells; TCR-engineered T cells; preparations for modifying human or animal cells for medical or therapeutic purposes; preparations of blood extracted from humans or animals which have been adapted for medical or therapeutic purposes
Goods and ServicesMedical services; veterinary services; services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies; providing advice and consultancy in the field of cancer therapies and cancer vaccines
Goods and ServicesScientific and technological services and research and design relating thereto; industrial analysis and research services; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies, including neoantigen-specific T cells and TCR-engineered T cells; scientific research in human and animal cell therapy; scientific research into vaccines, including personalised cancer vaccines and neoantigen vaccines; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 2, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAchilles Therapeutics UK Limited
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressLondon W68PW
GB

Trademark Events

Event DateEvent Description
Tuesday, April 2, 2024NEW APPLICATION ENTERED
Wednesday, July 17, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Saturday, September 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 15, 2024ASSIGNED TO EXAMINER

Related Keywords

achilles cells vaccines cancer research medical services animal preparations human therapeutic